Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283400 · ClinicalTrials.gov registry record · NA
Treatment of Subarachnoid Hemorrhage With Human Albumin
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT00283400 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 47 participants.
The verdict
NCT00283400, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the tolerability and safety of 25 percent human albumin therapy in patients with subarachnoid hemorrhage.
Interventions
- DRUG 25% human albumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2006-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283400
The ClinicalTrials.gov registry entry for NCT00283400 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 25% human albumin is the first listed.
NCT00283400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00283400 about?
NCT00283400 is a clinical study titled "Treatment of Subarachnoid Hemorrhage With Human Albumin". The purpose of this study is to evaluate the tolerability and safety of 25 percent human albumin therapy in patients with subarachnoid hemorrhage.
What is the current status of trial NCT00283400?
This trial is currently terminated. It is a NA study. The enrollment target is 47 participants. The study started on 2006-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00283400?
The interventions under investigation include: 25% human albumin (DRUG).
Who is sponsoring clinical trial NCT00283400?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.